Analysis of the Role of Female Hormones During Infection by COVID-19.
David Balbino PascoalIsabela Macêdo de AraujoLorenna Peixoto LopesCristiane Monteiro da CruzPublished in: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia (2021)
Women have metabolic, immunological, and genetic variables that ensure more protection from coronavirus infection. However, the indication of treatment for several pathologies and contraception is determined by hormones that have adverse effects and raise doubts about their use during the COVID-19 pandemic. Therefore, the present study searches women specificities and the relation between female sexual hormones and COVID-19, and reports the main recommendations in this background. To this end, a review of the literature was conducted in the main databases, auxiliary data sources, and official websites. Therefore, considering the hypercoagulability status of COVID-19, the debate about the use of contraceptives due to the relative risk of thromboembolic effects that they impose arises. However, the current available evidence, as well as the recommendations of main health organs around the world, demonstrate that the use of hormonal contraceptives must be maintained during the pandemic.
Keyphrases
- sars cov
- coronavirus disease
- polycystic ovary syndrome
- respiratory syndrome coronavirus
- mental health
- healthcare
- clinical practice
- public health
- pregnancy outcomes
- big data
- type diabetes
- genome wide
- insulin resistance
- drinking water
- gene expression
- atrial fibrillation
- metabolic syndrome
- copy number
- cervical cancer screening
- emergency department
- breast cancer risk
- risk assessment
- adverse drug
- data analysis
- health promotion